This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Legacy® Announces Bold Commitment To Jumpstart The Next Wave Of Declines In Youth Smoking

Grounding-breaking truth® Campaign to Amplify, Coordinate with Federal Anti-Tobacco Efforts; Major Agency Review to Be Conducted for New Work

WASHINGTON, July 25, 2013 /PRNewswire-USNewswire/ -- Legacy, the national public health non-profit created out of the landmark 1998 Master Settlement Agreement (MSA), today announced it will be launching agency reviews for its nationally recognized, proven-effective youth smoking prevention campaign, truth®.  The move signals a significant effort to expand the campaign at a time when the US Food & Drug Administration and US Centers for Disease Control and Prevention will be in the marketplace with bold anti-tobacco mass media initiatives. Together, the campaigns will serve as catalysts intended to spark a second wave of historic declines in tobacco use.  

To dramatically impact youth smoking prevalence nationally, Legacy recognizes that in today's cluttered media landscape, an increased investment in paid advertising is vital to reaching a national audience.  Over the next three years, Legacy will devote new and significant resources to truth®, to help augment the important work being conducted by the federal government in both youth prevention and adult cessation. This national paid advertising will supplement truth's extensive grassroots and digital outreach -- 'connecting all dots' with the youth audience that the campaign strives to reach in strategic ways.

This process marks a periodic review to build on the campaign's legacy and evolution by increasing its presence and reach among teens in the years to come. "Three proven-effective measures driving down youth smoking are: bold counter-marketing campaigns, price increases via state and federal tobacco excise taxes, and adoption of clean indoor air initiatives," said Cheryl G. Healton, DrPH, president and CEO of Legacy. "By increasing our investment in truth, we can expand its bold messaging and continue to save the lives of teens and young adults," Healton said.

"Every dollar counts when we have to compete with the billions of dollars that the tobacco industry spends each year promoting its deadly products," said Eric Asche, Legacy's Chief Marketing Officer. "It's a David versus Goliath fight and we're dependent on great partners to help us battle for market share.  We have nothing but the highest praise for Arnold Worldwide, PHD and the agencies with whom we've been so fortunate to work with over the course of the past 14 years. With this new infusion of funding and support for truth, we've got an unprecedented opportunity to look at the campaign anew and we're certain both agencies will take part in this review. Coupled with the historic efforts by the CDC and FDA, we're confident that 'this rising tide will lift all boats' and longer, healthier lives will be the result," he added.

Legacy will be reviewing both creative and media planning/buying agencies over the next several months and expects to make a decision by the end of the year.  Both incumbents are expected to defend.  Pile + Company will be handling the review.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs